Srini Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.70 Cr
- Paid Up Capital ₹ 2.36 Cr
- Company Age 29 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 92.10 Cr
- Satisfied Charges ₹ 80.58 Cr
- Revenue Growth 0.24%
- Profit Growth -163.47%
- Ebitda -82.47%
- Net Worth -3.97%
- Total Assets 0.68%
About Srini Pharmaceuticals
Srini Pharmaceuticals Private Limited (SPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 24 February 1995 and has a history of 29 years and 11 months. Its registered office is in Hyderabad - 500 033, Telangana.
The Corporate was formerly known as Srini Pharmaceuticals Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.70 Cr and a paid-up capital of Rs 2.36 Cr.
The company currently has active open charges totaling ₹92.10 Cr. The company has closed loans amounting to ₹80.58 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ravali Tera and Chinnapa Tera serve as directors at the Company.
Company Details
-
LocationHyderabad - 500 033, Telangana
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231TG1995PTC019543
-
Company No.
019543
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Feb 1995
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
What products or services does Srini Pharmaceuticals Private Limited offer?
Srini Pharmaceuticals Private Limited offers a wide range of products and services, including API Intermediate, API (Active Pharmaceutical Ingredients), Vitamin Tablets & Capsules, Folic Acid Tablet.
Who are the key members and board of directors at Srini Pharmaceuticals?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Chinnapa Tera | Managing Director | 06-Oct-1997 | Current |
Board Members (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ravali Tera | Whole-Time Director | 26-Dec-2022 | Current |
Financial Performance of Srini Pharmaceuticals.
Srini Pharmaceuticals Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 0.24% increase. The company also saw a substantial fall in profitability, with a 163.47% decrease in profit. The company's net worth dipped by a decrease of 3.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Srini Pharmaceuticals?
In 2022, Srini Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹92.10 Cr
₹80.58 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 86.10 Cr
- Industrial Development Bank Of India Ltd : 3.75 Cr
- State Bank Of Hyderabad : 2.25 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
14 Dec 2022 | Hdfc Bank Limited | ₹6.77 M | Open |
27 Oct 2021 | Hdfc Bank Limited | ₹1.37 Cr | Open |
25 Aug 2018 | Hdfc Bank Limited | ₹84.06 Cr | Open |
21 May 1997 | State Bank Of Hyderabad | ₹2.25 Cr | Open |
24 Apr 1996 | Industrial Development Bank Of India Ltd | ₹3.75 Cr | Open |
How Many Employees Work at Srini Pharmaceuticals?
Srini Pharmaceuticals has a workforce of 436 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Srini Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Srini Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.